The GOLD Podcast: Weekly Pharma Insights

In this episode, GOLD is joined by Davidek Herron, Global Head of Digital, Roche, who discusses his journey from professional basketball player to pharma leader, including the lessons he has taken from sport into business. He also shares his unique take on digital transformation and the secret to job satisfaction.

If you’re interested in learning more about the topic areas discussed in this episode, check out the following content:

A Cautionary Tale https://www.emg-gold.com/post/a-cautionary-tale

"We’ve lost the focus that we had on routine vaccination of preventable diseases" https://www.emg-gold.com/post/we-ve-lost-the-focus-that-we-had-on-routine-vaccination-of-preventable-diseases

A Debate On Digital Transformation https://www.emg-gold.com/post/a-debate-on-digital-transformation

"We need to create an equitable experience for all" https://www.emg-gold.com/post/we-need-to-create-an-equitable-experience-for-all

In this episode, GOLD is joined by Magnus Björsne, CEO, AstraZeneca BioVentureHub, who discusses the impact of the pandemic on innovation, collaboration and creativity within the industry. This episode also features a special diabetes-focused ‘Things you might have missed’, with news on novel management and monitoring technology for people living with diabetes.

If you’re interested in learning more about the topic areas discussed in this episode, check out the following content:

Nurturing home-grown innovation in Europe https://www.emg-gold.com/post/nurturing-home-grown-innovation-in-europe

A recipe for success in European healthcare https://www.emg-gold.com/post/a-recipe-for-success-in-european-healthcare

A big boom in biotech https://www.emg-gold.com/post/a-big-boom-in-biotech

The risks, rewards and future potential of biotechnology https://www.emg-gold.com/post/podcast-the-risks-rewards-and-future-potential-of-biotechnology

In this episode, GOLD is joined by Isabel Afonso, General Manager, Novartis Oncology China, who shares insights on the pharmaceutical landscape of the country and the potential of partnerships with multinational corporations, followed by a conversation with Dr Farid Khan, CEO and Founder, PharmaKure, about the vital ongoing need for drug development and the scientific details behind biopharmaceuticals. 

If you’re interested in learning more about the topic areas discussed in this episode, check out the following content: 

Pharma in… China https://www.emg-gold.com/post/pharma-in-china 

A big boom in biotech https://www.emg-gold.com/post/a-big-boom-in-biotech 

A heyday for mRNA https://www.emg-gold.com/post/a-heyday-for-mrna  

The vast galaxy of neurology https://www.emg-gold.com/post/the-vast-galaxy-of-neurology 

In this bonus episode, GOLD brings you the full feature-length interview with Claire Skentelbery, Director General, EuropaBio. She explores the contribution that biotech will have on Europe’s future and economic footprint, the preparedness of Europe to deliver biotech’s innovative therapies at scale, as well as the investment landscape for biotech-related SMEs. 

If you’re interested in learning more about the topic areas discussed in this episode, check out the following content:

A big boom in biotech https://www.emg-gold.com/post/a-big-boom-in-biotech

Nurturing homegrown innovation in Europe https://www.emg-gold.com/post/nurturing-home-grown-innovation-in-europe

The hard sell of cell and gene therapies https://www.emg-gold.com/post/the-hard-sell-of-cell-and-gene-therapies

In this episode, we speak to Claire Skentelbery, Director General, EuropaBio, about the biotech revolution, including how biotech companies could contribute to the European economy in the future and the readiness of Europe to deliver these innovative solutions at scale. The GOLD team also discusses the biotech revolution from an investor’s perspective, exploring the risks and rewards of investing in therapies driven by biotechnology.

Click here to subscribe to the weekly newsletter for more insights from GOLD.

If you’re interested in learning more about the topic areas discussed in this episode, check out the following content:

A big boom in biotech https://www.emg-gold.com/post/a-big-boom-in-biotech

Nurturing homegrown innovation in Europe https://www.emg-gold.com/post/nurturing-home-grown-innovation-in-europe

The hard sell of cell and gene therapies https://www.emg-gold.com/post/the-hard-sell-of-cell-and-gene-therapies

In this episode, Dr Nigel Guest, CEO, Trifolium Consulting, speaks to GOLD about his experiences as a GP during the pandemic, interactions with the pharma field force and his thoughts on the future of preventative medicines. Helena and Isabel additionally discuss the importance of making disease awareness campaigns really matter.

In this special bumper episode to mark International Women’s Day, Helena is joined by Nikki Jones, Head of Diversity, Equity and Inclusion at the Healthcare Businesswomen’s Association, to discuss the role of this global celebration within the health space. The team also speaks to Aliya Omer, Vice President and Head of Global Portfolio and Program Strategy at Kite Pharma, about how she navigated gender biases through her career. And the episode is topped off with a deep dive into GOLD features on gender parity with Isabel O’Brien, Assistant Editor – it’s an episode not to be missed!

If you’re interested in learning more about the topic areas discussed in this episode, check out the following content:

A discussion on the pandemic and gender parity https://www.emg-gold.com/post/a-discussion-on-the-pandemic-and-gender-parity

Diversity: from ideas to action https://www.emg-gold.com/post/diversity-from-ideas-to-action

Mind the pay gap https://www.emg-gold.com/post/mind-the-pay-gap

In this episode, GOLD talks to Liz Ashall-Payne, founder of ORCHA, a company that curates libraries of digital health apps for patients and healthcare professionals. She discusses the growing patient appetite for apps, the education that is needed for healthcare professionals and early considerations for pharma companies wishing to develop these solutions. GOLD also speaks to Dario Safaric, founder of the 'NEXT Pharma' conferences, about the upcoming ‘Next Normal’ event and pharma’s future in the metaverse.

If you’re interested in learning more about the topic areas discussed in this episode, check out the following content:

• Bridging the digital health divide https://www.emg-gold.com/post/bridging-the-digital-health-divide
• Spoonful of apps https://www.emg-gold.com/post/spoonful-of-apps
• Next Normal event https://nextpharmasummit.com/nextnormal/

In this episode, GOLD talks to Wayne Best, Chief Creative Officer, VMLY&R, who offers his insights on the innovative ‘I Will Always Be Me’ project with the MND Association – a fascinating and important cause with so much potential to inspire the pharma industry. But that’s not all! Join us to delve into the latest GOLD infographic on supply chain stability and hear the latest industry news you might have missed.

If you’re interested in learning more about the topic areas discussed in this episode, check out the following content:

• Risks to supply chain vulnerability – infographic https://www.emg-gold.com/_files/ugd/b8a9db_2fee0c32ea6940e69a36e4d939eedade.pdf
• Reacting to supply chain risks https://www.emg-gold.com/post/reacting-to-supply-chain-risks
• AI and Big Data at the forefront of pharma in 2022 https://www.emg-gold.com/post/ai-and-big-data-at-the-forefront-of-pharma-in-2022
• The latest GOLD issue, including the blockchain feature mentioned https://go.emg-gold.com/gold-20-access-form

The GOLD Podcast is back and better than ever! Tune into the first episode of Season 2 to hear the news you might have missed, exclusive extracts from GOLD’s catalyst interview with Judy Stewart, Senior Vice President and Head of US Vaccines, GSK, as well as a fascinating conversation with Independent Pharma Broker and blockchain enthusiast, Vincent Steine.

Click here to subscribe to the weekly newsletter for more insights from GOLD. https://www.emg-gold.com/subscribe 

If you are interested in learning more about the topic areas discussed in this episode, check out the following content:

GSK warns against routine vaccine complacency https://www.emg-gold.com/post/gsk-warns-against-routine-vaccine-complacency

Avalere Study – ‘How COVID-19 Has Impacted US Adolescent and Adult Vaccine Utilization’: https://avalere.com/insights/how-covid-19-has-impacted-us-adolescent-and-adult-vaccine-utilization

Hear more from Judy Stewart: “We’ve lost the focus that we had on routine vaccination of preventable diseases” https://www.emg-gold.com/post/we-ve-lost-the-focus-that-we-had-on-routine-vaccination-of-preventable-diseases

We’re back! The next season of the GOLD Podcast launches on 15^th February with a brand new format, more high profile guests and fresh industry insights – subscribe now to be the first to join hosts Marc and Helena and hear new episodes.

For the season finale of the GOLD Podcast, we look back at our 'GOLD Medal Moments' from the past 12 months, revisiting interviews with some of our top guests. Marc and Helena pick out the most important and challenging topics from 2021, including combatting misinformation, the evolving role of medical affairs, improving access to medicine and producing results in times of crisis.

In this episode, we talk to Margo Warren, Head of Policy at the Access to Medicine Foundation, who offers her thoughts on the ever-present need for global access to medicine. Margo discusses her path into the fight for health equality, the importance of global vaccine distribution, the changing philosophies behind bringing a product to market, and the move from reactive to pre-emptive research and development.

Join us in kicking off the new year with a special episode of the GOLD podcast, welcoming back six of our previous guests to share their predictions for what 2022 could bring for the pharmaceutical industry. They discuss a broad spectrum of topics ranging from new tech trends and clinical trial developments, to improvements in diversity and inclusion and patient centricity.

In this special end-of-year round up episode, three of this year’s GOLD Podcast guests return to review 2021 in the pharmaceutical industry. They discuss topics ranging from industry reputation to vaccine access, and celebrate and critique the year just past, while also looking ahead to 2022.

In this episode, we talk to Catherine Owen, Head of Major Markets at Bristol Myers Squibb, who discusses her path into the pharmaceutical industry and the upcoming changes to its data policies. Catherine explores the collection and storage of data, how we can ensure data systems are in place for the next pandemic, methods to build a new data culture and her key takeaways from the past year in pharma.

This week, we reflect on the highlights from the pharmaceutical industry that took place in November, covering the latest in COVID-19 developments, the most notable mergers and acquisitions, the standout awareness campaigns, and the latest in research and development news.

We talk to Tamika Jean-Baptiste, Vice President and Chief Diversity Officer, Amgen, who discusses her lifelong passion for diversity both in the workplace and in life. Tamika explores the importance of aligning your purpose and your passion, how best to draw young people into pharma, leveraging employee resource groups, and the significance of filling your own cup before reaching for others.

We speak to Chumi Khurana, Global Head, Prostate Cancer Disease Area Stronghold, Janssen Oncology about her pathway into men’s health, the challenges and potential solutions in the realm of prostate disease, and her advice for family and caregivers on how best to support a loved one who is dealing with a prostate cancer diagnosis.

We talk to Dr Richard Kaszynski, Chief Medical Officer, AiPharma, who discusses the emerging role of antivirals in healthcare. He explores his work on the GUARDIAN program, the benefits of drug repurposing, the importance of keeping patients out of hospitals and his highlights from the past year.